(Q47868287)

6 February 2018

title

Cyclothymic OCD: a distinct form? (English)

1 reference

6 February 2018

obsessive-compulsive disorder

main subject

1 reference

Hantouche EG

1

1 reference

6 February 2018

Angst J

2

1 reference

6 February 2018

Demonfaucon C

3

1 reference

6 February 2018

Perugi G

4

1 reference

6 February 2018

Lancrenon S

5

1 reference

6 February 2018

Akiskal HS

6

1 reference

6 February 2018

publication date

1 June 2003

1 reference

6 February 2018

Journal of Affective Disorders

published in

1 reference

6 February 2018

volume

75

1 reference

6 February 2018

page(s)

1-10

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Bipolar II with and without cyclothymic temperament: "dark" and "sunny" expressions of soft bipolarity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Rating scales for mania: is self-rating reliable?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

The emerging epidemiology of hypomania and bipolar II disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Antidepressant induced mania in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

The feasibility of self-assessment of dysphoric mania in the French national EPIMAN study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Episodic course in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Depressive comorbidity of panic, social phobic, and obsessive–compulsive disorders re-examined: is there a bipolar ii connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2802%2900461-5

7 January 2021

10.1016/S0165-0327(02)00461-5

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

12781344

1 reference

6 February 2018